Current Status of COVID‐19 (Pre)Clinical Vaccine Development-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Current Status of COVID‐19 (Pre)Clinical Vaccine Development

Published:2020-09-02 Issue:43 Volume:59 Page:18885-18897
ISSN:1433-7851
Container-title:Angewandte Chemie International Edition
language:en
Short-container-title:Angew. Chem. Int. Ed.

Author:

Ye Tingting¹,Zhong Zifu¹,García‐Sastre Adolfo²³⁴⁵,Schotsaert Michael²³,De Geest Bruno G.¹^ORCID

Affiliation:

1. Department of Pharmaceutics Ghent University Belgium

2. Department of Microbiology Icahn School of Medicine at Mount Sinai New York NY 10029 USA

3. Global Health and Emerging Pathogens Institute Icahn School of Medicine at Mount Sinai New York NY 10029 USA

4. Department of Medicine Division of Infectious Diseases Icahn School of Medicine at Mount Sinai New York NY 10029 USA

5. The Tisch Cancer Institute Icahn School of Medicine at Mount Sinai New York NY 10029 USA

Publisher

Wiley

Subject

General Chemistry,Catalysis

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/anie.202008319

Reference111 articles.

1. A new coronavirus associated with human respiratory disease in China

2. Complete Protection against Severe Acute Respiratory Syndrome Coronavirus-Mediated Lethal Respiratory Disease in Aged Mice by Immunization with a Mouse-Adapted Virus Lacking E Protein

3. Immunogenicity of an adenoviral-based Middle East Respiratory Syndrome coronavirus vaccine in BALB/c mice

4. Long-lived effector/central memory T-cell responses to severe acute respiratory syndrome coronavirus (SARS-CoV) S antigen in recovered SARS patients

5. A SARS DNA vaccine induces neutralizing antibody and cellular immune responses in healthy adults in a Phase I clinical trial

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CO-DELIVERY of glutamic acid-extended peptide antigen and imidazoquinoline TLR7/8 agonist via ionizable lipid nanoparticles induces protective anti-tumor immunity;Biomaterials;2024-12

2. A Narrative Overview of Coronavirus Infection: Clinical Signs and Symptoms, Viral Entry and Replication, Treatment Modalities, and Management;Current Topics in Medicinal Chemistry;2024-08

3. Incidence and management of the main serious adverse events reported after COVID‐19 vaccination;Pharmacology Research & Perspectives;2024-06

4. Eco‐friendly materials for next‐generation vaccination: From concept to clinical reality;SmartMat;2024-01-31

5. RNA therapeutics for infectious diseases;Progress in Molecular Biology and Translational Science;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3